WHO ICTRP trial
Application of remimazolam in patients undergoing radical resection of…
ChiCTR2200064049 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200064049 |
|---|---|
| Public title | Application of remimazolam in patients undergoing radical resection of esophageal cancer under general anesthesia |
| Scientific title | Application of remimazolam in patients undergoing radical resection of esophageal cancer under general anesthesia |
| Primary sponsor | Affiliated Cancer Hospital of Zhengzhou University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Esophageal cancer |
| Interventions | Control group:Sedation under general anesthesia was done by intravenous propofol;Experimental group:Sedation under general anesthesia was done by intravenous remimazolam |
| Registration date | Sep 24, 2022 |
| Target size | Control group:30;Experimental group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: